Annual D&A
$6.24 M
-$386.00 K-5.82%
December 31, 2023
Summary
- As of February 12, 2025, MCRB annual depreciation & amortization is $6.24 million, with the most recent change of -$386.00 thousand (-5.82%) on December 31, 2023.
- During the last 3 years, MCRB annual D&A has fallen by -$335.00 thousand (-5.09%).
- MCRB annual D&A is now -20.59% below its all-time high of $7.86 million, reached on December 31, 2018.
Performance
MCRB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.40 M
-$16.00 K-1.13%
September 30, 2024
Summary
- As of February 12, 2025, MCRB quarterly depreciation & amortization is $1.40 million, with the most recent change of -$16.00 thousand (-1.13%) on September 30, 2024.
- Over the past year, MCRB quarterly D&A has dropped by -$228.00 thousand (-13.97%).
- MCRB quarterly D&A is now -30.01% below its all-time high of $2.01 million, reached on March 31, 2019.
Performance
MCRB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$6.01 M
-$280.00 K-4.45%
September 30, 2024
Summary
- As of February 12, 2025, MCRB TTM depreciation & amortization is $6.01 million, with the most recent change of -$280.00 thousand (-4.45%) on September 30, 2024.
- Over the past year, MCRB TTM D&A has dropped by -$228.00 thousand (-3.65%).
- MCRB TTM D&A is now -24.12% below its all-time high of $7.93 million, reached on March 31, 2019.
Performance
MCRB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
MCRB Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.8% | -14.0% | -3.6% |
| 3 y3 years | -5.1% | -13.7% | -9.3% |
| 5 y5 years | -20.6% | -13.7% | -9.3% |
MCRB Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +5.0% | -19.6% | +0.3% | -9.3% | +1.1% |
| 5 y | 5-year | -17.9% | +5.0% | -22.1% | +0.3% | -20.9% | +1.9% |
| alltime | all time | -20.6% | >+9999.0% | -30.0% | +4580.0% | -24.1% | >+9999.0% |
Seres Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.40 M(-1.1%) | $6.01 M(-4.4%) |
| Jun 2024 | - | $1.42 M(-8.9%) | $6.29 M(-1.7%) |
| Mar 2024 | - | $1.56 M(-4.5%) | $6.40 M(+2.5%) |
| Dec 2023 | $6.24 M(-5.8%) | $1.63 M(-3.1%) | $6.24 M(+0.1%) |
| Sep 2023 | - | $1.68 M(+10.3%) | $6.24 M(-1.0%) |
| Jun 2023 | - | $1.53 M(+9.1%) | $6.30 M(-2.4%) |
| Mar 2023 | - | $1.40 M(-14.0%) | $6.46 M(-2.6%) |
| Dec 2022 | $6.63 M(+11.5%) | $1.63 M(-6.9%) | $6.63 M(+1.1%) |
| Sep 2022 | - | $1.75 M(+3.7%) | $6.55 M(+4.0%) |
| Jun 2022 | - | $1.69 M(+7.3%) | $6.30 M(+4.3%) |
| Mar 2022 | - | $1.57 M(+1.2%) | $6.04 M(+1.6%) |
| Dec 2021 | $5.95 M(-9.6%) | $1.55 M(+4.0%) | $5.95 M(+0.7%) |
| Sep 2021 | - | $1.49 M(+4.7%) | $5.90 M(-1.4%) |
| Jun 2021 | - | $1.43 M(-3.4%) | $5.99 M(-4.2%) |
| Mar 2021 | - | $1.48 M(-2.2%) | $6.25 M(-5.0%) |
| Dec 2020 | $6.58 M(-13.5%) | $1.51 M(-4.3%) | $6.58 M(-4.2%) |
| Sep 2020 | - | $1.58 M(-6.8%) | $6.87 M(-4.2%) |
| Jun 2020 | - | $1.69 M(-6.2%) | $7.17 M(-3.1%) |
| Mar 2020 | - | $1.80 M(+0.1%) | $7.40 M(-2.7%) |
| Dec 2019 | $7.60 M | $1.80 M(-4.1%) | $7.60 M(-2.5%) |
| Sep 2019 | - | $1.88 M(-2.3%) | $7.80 M(-1.2%) |
| Jun 2019 | - | $1.92 M(-4.2%) | $7.89 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $2.01 M(+0.7%) | $7.93 M(+0.8%) |
| Dec 2018 | $7.86 M(+8.3%) | $1.99 M(+1.0%) | $7.86 M(+1.2%) |
| Sep 2018 | - | $1.97 M(+1.0%) | $7.77 M(+1.4%) |
| Jun 2018 | - | $1.95 M(+0.7%) | $7.66 M(+2.6%) |
| Mar 2018 | - | $1.94 M(+2.0%) | $7.47 M(+2.9%) |
| Dec 2017 | $7.26 M(+72.6%) | $1.90 M(+2.0%) | $7.26 M(+3.0%) |
| Sep 2017 | - | $1.87 M(+6.0%) | $7.05 M(+9.6%) |
| Jun 2017 | - | $1.76 M(+1.7%) | $6.43 M(+16.0%) |
| Mar 2017 | - | $1.73 M(+2.1%) | $5.55 M(+32.0%) |
| Dec 2016 | $4.21 M(+477.6%) | $1.69 M(+35.4%) | $4.21 M(+47.8%) |
| Sep 2016 | - | $1.25 M(+43.1%) | $2.85 M(+60.2%) |
| Jun 2016 | - | $874.00 K(+126.4%) | $1.78 M(+73.8%) |
| Mar 2016 | - | $386.00 K(+15.6%) | $1.02 M(+40.4%) |
| Dec 2015 | $728.00 K(+283.2%) | $334.00 K(+83.5%) | $728.00 K(+54.6%) |
| Sep 2015 | - | $182.00 K(+51.7%) | $471.00 K(+40.2%) |
| Jun 2015 | - | $120.00 K(+30.4%) | $336.00 K(+33.3%) |
| Mar 2015 | - | $92.00 K(+19.5%) | $252.00 K(+32.6%) |
| Dec 2014 | $190.00 K(+115.9%) | $77.00 K(+63.8%) | $190.00 K(+68.1%) |
| Sep 2014 | - | $47.00 K(+30.6%) | $113.00 K(+71.2%) |
| Jun 2014 | - | $36.00 K(+20.0%) | $66.00 K(+120.0%) |
| Mar 2014 | - | $30.00 K | $30.00 K |
| Dec 2013 | $88.00 K(+252.0%) | - | - |
| Dec 2012 | $25.00 K | - | - |
FAQ
- What is Seres Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Seres Therapeutics?
- What is Seres Therapeutics annual D&A year-on-year change?
- What is Seres Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Seres Therapeutics?
- What is Seres Therapeutics quarterly D&A year-on-year change?
- What is Seres Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Seres Therapeutics?
- What is Seres Therapeutics TTM D&A year-on-year change?
What is Seres Therapeutics annual depreciation & amortization?
The current annual D&A of MCRB is $6.24 M
What is the all time high annual D&A for Seres Therapeutics?
Seres Therapeutics all-time high annual depreciation & amortization is $7.86 M
What is Seres Therapeutics annual D&A year-on-year change?
Over the past year, MCRB annual depreciation & amortization has changed by -$386.00 K (-5.82%)
What is Seres Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of MCRB is $1.40 M
What is the all time high quarterly D&A for Seres Therapeutics?
Seres Therapeutics all-time high quarterly depreciation & amortization is $2.01 M
What is Seres Therapeutics quarterly D&A year-on-year change?
Over the past year, MCRB quarterly depreciation & amortization has changed by -$228.00 K (-13.97%)
What is Seres Therapeutics TTM depreciation & amortization?
The current TTM D&A of MCRB is $6.01 M
What is the all time high TTM D&A for Seres Therapeutics?
Seres Therapeutics all-time high TTM depreciation & amortization is $7.93 M
What is Seres Therapeutics TTM D&A year-on-year change?
Over the past year, MCRB TTM depreciation & amortization has changed by -$228.00 K (-3.65%)